Breaking● Reported

PasatruTM (garetosmab-grts) Demonstrates Zero New Heterotopic Ossification (HO) Lesions in Adult Fibrodysplasia Ossificans Progressiva (FOP) Patients During OPTIMA Trial Extension

Opened 12 Oct 2026 23:06 WIB · last update 12 Oct 2026 23:06 WIB · 1 sources

reported 12 Oct 23:06 · reported by: Business Insider — Markets

Market reaction

Linked assets at the first close after the story opened, against the close before. Timing, not proof of cause.

No linked market series, or no close yet after the story opened.

Who is covering it

Distinct sources by type; one outlet counts once.

News 1

What the updates added

New fact · 1

Story timeline

Monday 12 Oct 2026

23:06

New fact Business Insider — Markets

first report

◆ official · ● news · 𝕏 X · ▶ video · ▲▼ market move · X posts: link and metadata only.